Rethinking Gastroscopy referrals in the UK – Is it time for triage?
November 18, 2025
Gastric cancer is a significant global health burden, with rising frequency and mortality rates. It ranks as the sixth most common cancer worldwide, with an age-standardised incidence rate of 11.1.
About BIOHIT HealthCare
BIOHIT HealthCare is a Finnish biotech company, headquartered in Helsinki, that specialises in the development, manufacture and distribution of kits and assays for the screening, diagnosis and monitoring of digestive diseases. Its core disease focus areas include stomach health and dyspepsia, reflux and acid dysregulation, Inflammatory Bowel Disease (IBD), functional gastrointestinal disorders (FGID), Irritable bowel syndrome (IBS), and gut microbiota dysbiosis. Innovating for Health www.biohithealthcare.co.uk
